Reagena Oy
Ilpo Kuronen is a seasoned professional with extensive experience in leadership roles within the healthcare and technology sectors. As the Chief Executive Officer and Chief Technology Officer at Reagena Oy Ltd since May 2021, Ilpo has driven significant developments in the company. Prior experience includes serving as a Business Development Manager at the University of Eastern Finland and R2 Therapies from December 2019 to May 2023, along with various roles at Hapella Oy, including Scientific Adviser and CEO, contributing to the development of the WellO2 respiratory care device. Ilpo also held the position of Programme Director at Kuopio Innovation Oy, overseeing the National Health and Wellbeing Cluster Programme, and served as Director of R&D at Oy REAGENA Ltd. Ilpo's early career includes leadership as CEO at Oy ERILAB Ltd and project management with the WellO2 team. Educational qualifications include a PhD in Clinical Biochemistry from the University of Eastern Finland.
This person is not in any teams
This person is not in any offices
Reagena Oy
Reagena is a biotechnology company developing, manufacturing and selling internationally proven, high quality products for healthcare laboratories, industry and pharmacies. Reagena’s core competencies include: • Development of award-winning immunological point-of-care tests and enzyme immunoassays for diagnosing infectious diseases such as lyme, tick-borne encephalitis and hantavirus • Production of reagents, staining solutions, buffers and fixatives for life sciences and industry • Execution of contract manufacturing and product development services • Distribution of leading diagnostics brands in the Nordic region Reagena products are manufactured in Toivala, Finland, according to ISO 9001 and ISO 13485 certified quality management systems. Read more at http://www.reagena.com/en